Back to Zacks Investment Management Zacks Investment Management

JANXJANX

Showing 5 of 8 quarters

Position history for Zacks Investment ManagementZacks Investment Management's holdings in Janux Therapeutics, Inc.

No. Zacks Investment Management exited its JANX (Janux Therapeutics) position in Q3 2025. Its Q2 2025 13F listed 37,968 shares worth $877,068. Zacks Investment Management first reported JANX in Q4 2023 and held it in 7 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$1.9M

Total Shares Change

-42,133

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q3
Latest
Exited
0
-100.0%
$00.0%$24.44
0
2025-Q2
Decreased
37,968
-0.4%
$877,0680.0%$23.15
0
2025-Q1
Decreased
38,122
-0.1%
$1M0.0%$29.10
0
2024-Q4
Decreased
38,173
-9.4%
$2M0.0%$52.50
0
2024-Q3
Increased
42,133
+8.7%
$1.9M0.0%$46.25
28

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used